search
Back to results

A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities (REPICAL)

Primary Purpose

Depression, Anxiety, Psychological Distress

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Doing What Matters (DWM)
Problem Management Plus (PM+)
Psychological First Aid (PFA)
Sponsored by
Fundació Sant Joan de Déu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Depression

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years or older;
  • Having elevated levels of psychological distress (Kessler Psychological Distress Scale (K10) >15.9).
  • Written/digital informed consent before entering the study.
  • Working in ALFs located in Catalonia (e.g., physicians, nurses, nursing assistants, technicians, and those that are not directly involved in patient care but potentially exposed to infectious agents such as administrative staff)

Exclusion Criteria:

  • Having acute medical conditions (requiring hospitalization)
  • Imminent suicide risk, or expressed acute needs, or protection risks that require immediate follow-up
  • Having a severe mental disorder (e.g., psychotic disorders, substance-dependence)
  • Having severe cognitive impairment (e.g., severe intellectual disability or dementia)
  • Currently specialized psychological treatment (e.g., Eye movement desensitization and reprocessing, Cognitive behavioral therapy)
  • In case of current psychotropic medication use, being on an unstable dose for at least 2 months.

Sites / Locations

  • Parc Sanitari Sant Joan de DéuRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Stepped-care program (Step 1: DWM; Step 2: PM+)

Psychological First Aid (PFA)

Arm Description

The treatment group will first receive Psychological First Aid (PFA). PFA consists of a 15-min call that assess the immediate concerns and needs of an individual in order to connect individuals to help and resources. Afterwards participants will receive the stepped-care program consisting of Doing What Matters (DWM) (step 1) and Problem Management Plus (PM+) (step 2). Step 2 will only be provided if the participant still has elevated levels of psychological distress (i.e. during the second quantitative assessment at 2 weeks after DWM). Participants will also be allowed to continue with their mental health interventions (CAU), as long as they meet eligibility criteria. Interventions: Behavioral: Doing What Matters (DWM) Behavioral: Problem Management Plus (PM+) Behavioral: Psychological First Aid (PFA)

Participants allocated to the control arm will also receive PFA. Participants will also be allowed to continue with their mental health interventions (CAU), as long as they meet eligibility criteria. Intervention: Behavioral: Psychological First Aid (PFA)

Outcomes

Primary Outcome Measures

Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
The PHQ-ADS is a 16-item self-reported instrument that combines the nine-item Patient Health Questionnaire depression scale and seven-item Generalized Anxiety Disorder scale-as a composite measure of depression and anxiety. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 48, with higher scores indicating higher levels of depression and anxiety symptomatology.

Secondary Outcome Measures

Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
The PHQ-ADS is a 16-item self-reported instrument that combines the nine-item Patient Health Questionnaire depression scale and seven-item Generalized Anxiety Disorder scale-as a composite measure of depression and anxiety. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 48, with higher scores indicating higher levels of depression and anxiety symptomatology.
Patient Health Questionnaire (PHQ-9)
The PHQ-9 is a 9-item self-reported instrument that measures depression symptoms. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 27, with higher scores indicating higher levels of depression.
Generalized Anxiety Disorder (GAD-7) scale
The GAD-7 is a 7-item self-reported instrument that measures anxiety symptoms. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 21, with higher scores indicating higher levels of anxiety.
Posttraumatic Stress Disorder (PTSD) Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (PCL-5) - 8-item version
The PCL-5 is a self-reported instrument that measures PTSD symptoms. Respondents are asked how much each symptom has bothered them over the past 4 weeks, with response options of "not at all", "a little bit", "moderately", "quite a bit", and "extremely". Items are rated on a 0-4 scale. The scale can range from 0 to 32 for the 8-item version, with higher scores indicating higher levels of PTSD symptoms.
EuroQol 5-dimensional descriptive system - 5-level version (EQ-5D-5L)
The EQ-5D-5L measures quality of life and consists of two parts, the EQ-5D and the EQ VAS. Part 1, the EQ-5D, rates the level of impairment across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The labels for the 5L followed the format "no problems," "slight problems," "moderate problems," "severe problems," and "unable to"/"extreme problems" for all dimensions. For mobility, the description of "confined to bed" has been changed to "unable to walk about.". Part 2, the EQ-VAS, is a visual analogue scale. The endpoints of the scale are called 'The best health you can imagine' and 'The worst health you can imagine' and the current health status of that day needs to be indicated, after which the number checked on the scale also needs to be written down. Higher scores indicate worst qualitive of life.
Client Service Receipt Inventory (CSRI) - adaptation
The CSRI was developed for the collection of data on service utilization (e.g. use of health system, other services, time out of employment and other usual activities, need for informal care) and related characteristics of people with mental disorders, as the basis for calculating the costs of care for mental health cost-effectiveness research. The RESPOND-adapted version consists of a 13-item self-reported instrument that asks about the number and duration of contacts with healthcare professionals (physicians, mental health specialists, and nurses) in the past two months.

Full Information

First Posted
July 21, 2022
Last Updated
September 27, 2022
Sponsor
Fundació Sant Joan de Déu
Collaborators
VU University of Amsterdam, Universidad Autonoma de Madrid
search

1. Study Identification

Unique Protocol Identification Number
NCT05526235
Brief Title
A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities
Acronym
REPICAL
Official Title
Reducing the Psychosocial Impact of the Covid-19 Pandemic on Workers of Assisted Living Facilities
Study Type
Interventional

2. Study Status

Record Verification Date
September 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 27, 2022 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
September 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fundació Sant Joan de Déu
Collaborators
VU University of Amsterdam, Universidad Autonoma de Madrid

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: The COVID-19 pandemic has impacted the mental health of workers of Assisted Living Facilities (ALFs). This study combines two low-intensity psychological interventions developed by the World Health Organization (Doing What Matters [DWM] and Problem Management Plus [PM+]) into a stepped-care program for workers of ALFs. Objective: To evaluate the implementation of an stepped-care program (DWM; PM+) amongst workers of ALFs during the COVID-19 pandemic in terms of mental distress, resilience and wellbeing. Study design: A randomized controlled implementation trial with an single-blinded, parallel-group design. Study population: Workers of ALFs with self-reported elevated psychological distress. Intervention-study: All participants (in both the treatment and the comparison group) will receive Psychological First Aid (PFA) and care as usual (CAU). In addition to PFA and CAU, the treatment group will receive the stepped-care intervention (DWM with or without PM+). The stepped-care intervention consists of DWM (step 1) and conditionally PM+ (step 2) if participants still meet criteria for psychological distress (Kessler Psychological Distress scale (K10) >15.9) 1 month after having received DWM. Main study parameters/endpoints: Screening for inclusion and exclusion criteria will be interviewer-administered through phone calls. All assessments will be online and will take place at baseline, 2 weeks after having received DWM, 1 week after having received PM+ and 2 months after PM+. The main study parameter will be the decrease of anxiety and depressive symptoms from baseline to two-month follow-up, measured through the sum score of the Patient Health Questionnaire (PHQ-9) and General Anxiety Disorder-7 (GAD-7), i.e. the PHQ-Anxiety and Depression Score (PHQ-ADS).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety, Psychological Distress

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
105 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Stepped-care program (Step 1: DWM; Step 2: PM+)
Arm Type
Experimental
Arm Description
The treatment group will first receive Psychological First Aid (PFA). PFA consists of a 15-min call that assess the immediate concerns and needs of an individual in order to connect individuals to help and resources. Afterwards participants will receive the stepped-care program consisting of Doing What Matters (DWM) (step 1) and Problem Management Plus (PM+) (step 2). Step 2 will only be provided if the participant still has elevated levels of psychological distress (i.e. during the second quantitative assessment at 2 weeks after DWM). Participants will also be allowed to continue with their mental health interventions (CAU), as long as they meet eligibility criteria. Interventions: Behavioral: Doing What Matters (DWM) Behavioral: Problem Management Plus (PM+) Behavioral: Psychological First Aid (PFA)
Arm Title
Psychological First Aid (PFA)
Arm Type
Active Comparator
Arm Description
Participants allocated to the control arm will also receive PFA. Participants will also be allowed to continue with their mental health interventions (CAU), as long as they meet eligibility criteria. Intervention: Behavioral: Psychological First Aid (PFA)
Intervention Type
Behavioral
Intervention Name(s)
Doing What Matters (DWM)
Other Intervention Name(s)
Doing What Matters in Times of Stress, Self Help Plus, DWM, SH+
Intervention Description
The original DWM program consists of a self-help guide called 'Doing What Matters in Times of Stress', that is complemented with pre-recorded audio exercises. The audio material imparts key information about stress management and guides participants through individual exercises. Additionally, participants are guided by a briefly trained helper. In this study, DWM will be delivered as an online intervention. The DWM intervention, i.e. both the audio recordings and the self-help guide, has been adapted for use on a smartphone or other device with internet access. The format of DWM is innovative in that it seeks to ensure that key intervention components are delivered as intended through the use of pre-recorded audio, without the burden of extensive training and supervision. In the online application tool a new module is released every week so participants will be asked to go through the entire DWM intervention within 5 weeks with weekly guidance from a helper.
Intervention Type
Behavioral
Intervention Name(s)
Problem Management Plus (PM+)
Other Intervention Name(s)
PM+
Intervention Description
PM+ is a new, brief, psychological intervention program based on cognitive behavioral therapy (CBT) techniques. The manual involves the following empirically supported elements: problem solving plus stress management, behavioral activation, facing fears, and accessing social support. Across the five 90-minute sessions participants may talk to trained non-professional. PM+ has four core features, and it is brief. In this study, the delivery mode of the PM+ intervention will be flexible, with remote delivery in phases of the pandemic when physical distancing rules apply. This is a future-oriented attempt towards a more holistic mental health care system that can flexibly switch between modes of delivery (e.g. remotely (e.g. Zoom) or face-to), depending on the needs and the specific containment measures that apply, and the specific preferences and needs of the participant.
Intervention Type
Behavioral
Intervention Name(s)
Psychological First Aid (PFA)
Other Intervention Name(s)
PFA
Intervention Description
PFA is a brief intervention consisting of a 15-min call that assess the immediate concerns and needs of an individual in order to connect individuals to help and resources.
Primary Outcome Measure Information:
Title
Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
Description
The PHQ-ADS is a 16-item self-reported instrument that combines the nine-item Patient Health Questionnaire depression scale and seven-item Generalized Anxiety Disorder scale-as a composite measure of depression and anxiety. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 48, with higher scores indicating higher levels of depression and anxiety symptomatology.
Time Frame
Change from baseline to 20 weeks
Secondary Outcome Measure Information:
Title
Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS)
Description
The PHQ-ADS is a 16-item self-reported instrument that combines the nine-item Patient Health Questionnaire depression scale and seven-item Generalized Anxiety Disorder scale-as a composite measure of depression and anxiety. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 48, with higher scores indicating higher levels of depression and anxiety symptomatology.
Time Frame
Change: Baseline, 6 weeks, and 12 weeks
Title
Patient Health Questionnaire (PHQ-9)
Description
The PHQ-9 is a 9-item self-reported instrument that measures depression symptoms. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 27, with higher scores indicating higher levels of depression.
Time Frame
Baseline, 6 weeks, 12 weeks, and 20 weeks
Title
Generalized Anxiety Disorder (GAD-7) scale
Description
The GAD-7 is a 7-item self-reported instrument that measures anxiety symptoms. Respondents are asked how much each symptom has bothered them over the past 2 weeks, with response options of "not at all", "several days", "more than half the days", and "nearly every day", scored as 0, 1, 2, and 3. The scale can range from 0 to 21, with higher scores indicating higher levels of anxiety.
Time Frame
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks
Title
Posttraumatic Stress Disorder (PTSD) Checklist for Diagnostic and Statistical Manual of Mental Disorders (DSM-5) (PCL-5) - 8-item version
Description
The PCL-5 is a self-reported instrument that measures PTSD symptoms. Respondents are asked how much each symptom has bothered them over the past 4 weeks, with response options of "not at all", "a little bit", "moderately", "quite a bit", and "extremely". Items are rated on a 0-4 scale. The scale can range from 0 to 32 for the 8-item version, with higher scores indicating higher levels of PTSD symptoms.
Time Frame
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks
Title
EuroQol 5-dimensional descriptive system - 5-level version (EQ-5D-5L)
Description
The EQ-5D-5L measures quality of life and consists of two parts, the EQ-5D and the EQ VAS. Part 1, the EQ-5D, rates the level of impairment across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The labels for the 5L followed the format "no problems," "slight problems," "moderate problems," "severe problems," and "unable to"/"extreme problems" for all dimensions. For mobility, the description of "confined to bed" has been changed to "unable to walk about.". Part 2, the EQ-VAS, is a visual analogue scale. The endpoints of the scale are called 'The best health you can imagine' and 'The worst health you can imagine' and the current health status of that day needs to be indicated, after which the number checked on the scale also needs to be written down. Higher scores indicate worst qualitive of life.
Time Frame
Baseline, 6 weeks, 12 weeks, and 20 weeks
Title
Client Service Receipt Inventory (CSRI) - adaptation
Description
The CSRI was developed for the collection of data on service utilization (e.g. use of health system, other services, time out of employment and other usual activities, need for informal care) and related characteristics of people with mental disorders, as the basis for calculating the costs of care for mental health cost-effectiveness research. The RESPOND-adapted version consists of a 13-item self-reported instrument that asks about the number and duration of contacts with healthcare professionals (physicians, mental health specialists, and nurses) in the past two months.
Time Frame
Change: Baseline, 6 weeks, 12 weeks, and 20 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years or older; Having elevated levels of psychological distress (Kessler Psychological Distress Scale (K10) >15.9). Written/digital informed consent before entering the study. Working in ALFs located in Catalonia (e.g., physicians, nurses, nursing assistants, technicians, and those that are not directly involved in patient care but potentially exposed to infectious agents such as administrative staff) Exclusion Criteria: Having acute medical conditions (requiring hospitalization) Imminent suicide risk, or expressed acute needs, or protection risks that require immediate follow-up Having a severe mental disorder (e.g., psychotic disorders, substance-dependence) Having severe cognitive impairment (e.g., severe intellectual disability or dementia) Currently specialized psychological treatment (e.g., Eye movement desensitization and reprocessing, Cognitive behavioral therapy) In case of current psychotropic medication use, being on an unstable dose for at least 2 months.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mireia Felez-Nobrega, PhD
Phone
936406350
Ext
12540
Email
mireia.felez@sjd.es
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Monistrol-Mula, MSc
Phone
936406350
Ext
2543
Email
anna.monistrol@sjd.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Josep Maria Haro, MD,PhD
Organizational Affiliation
Fundació Sant Joan de Déu
Official's Role
Principal Investigator
Facility Information:
Facility Name
Parc Sanitari Sant Joan de Déu
City
Sant Boi de Llobregat
State/Province
Barcelona
ZIP/Postal Code
08930
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Josep Maria Haro, MD, PHD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities

We'll reach out to this number within 24 hrs